Form D · Biotechnology

VITROLABS INC

Milpitas, CA · CIK 0001881943

Offering snapshot reported May 17, 2022 · SEC filing

Reported sold
$47.4M
Offering amount: $47.4M
Investors reported
60
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 17, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$23.7M$47.4MSep 24, 2021: $21,657,512.00Sep 24, 2021May 17, 2022: $47,400,572.00May 17, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$21,657,512 → $47,400,572
  • Reported investors41 → 60

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 17, 2022Amendment$47,400,572$25,743,060vs Sep 24, 202160SEC filing
Sep 24, 2021Initial$21,657,512No comparison41SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-414555
Total amount sold includes $13,142,052.05 of converted and/or cancelled indebtedness and accrued interest.

Source: Form D, filed May 17, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Martin Avetisyan Director
Anthony Chow Director
Ingvar Helgason Director, Executive, Promoter
Dusko Ilic Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1561 Buckeye Drive
Milpitas, CA, 95035